MARKET

NRSNW

NRSNW

Neurosense Therapeutics Ltd
NASDAQ
0.0055
0.0000
0.00%
Closed 09:30 11/19 EST
OPEN
0.0055
PREV CLOSE
0.0055
HIGH
0.0055
LOW
0.0055
VOLUME
6
TURNOVER
306
52 WEEK HIGH
0.4499
52 WEEK LOW
0.0011
MARKET CAP
--
P/E (TTM)
-0.0027
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRSNW last week (1109-1113)?
Weekly Report · 4d ago
Weekly Report: what happened at NRSNW last week (1102-1106)?
Weekly Report · 11/09 09:56
Weekly Report: what happened at NRSNW last week (1026-1030)?
Weekly Report · 11/02 09:56
Weekly Report: what happened at NRSNW last week (1019-1023)?
Weekly Report · 10/26 09:56
NeuroSense Therapeutics Files U.S. Patent Application Covering Methods Of Treating Traumatic Brain Injury And Related Central Nervous System Injuries With Combination Of Ciprofloxacin And Celecoxib
Benzinga · 10/19 12:28
Weekly Report: what happened at NRSNW last week (1012-1016)?
Weekly Report · 10/19 09:56
NeuroSense Appeals Nasdaq Delisting Determination, Hearing Date Set For Nov. 10
NASDAQ · 10/14 09:17
NeuroSense Therapeutics Announces Nasdaq Hearings Panel Date Of November 10; Minimum Bid Price Compliance Already Regained; Sees PrimeC Milestones In December And Q1 2027
Benzinga · 10/13 12:38
More
About NRSNW
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Webull offers Neurosense Therapeutics Ltd stock information, including NASDAQ: NRSNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRSNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRSNW stock methods without spending real money on the virtual paper trading platform.